Itau Unibanco Holding S.A. Jounce Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.81 - $9.21 $1,067 - $3,499	-380 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $1,982 - $3,102	-461 Reduced 54.82%	380 $2,000
Q4 2018 Feb 13, 2019	BUY	$2.69 - $6.71 $142 - $355	53 Added 6.73%	841 $3,000
Q3 2018 Nov 13, 2018	SELL	$6.5 - $8.37 $110 - $142	-17 Reduced 2.11%	788 $5,000
Q2 2018 Aug 13, 2018	SELL	$7.27 - $21.88 $7 - $21	-1 Reduced 0.12%	805 $6,000
Q1 2018 May 14, 2018	BUY	$13.4 - $28.4 $7,544 - $15,989	563 Added 231.69%	806 $18,000
Q4 2017 Feb 09, 2018	BUY	$12.52 - $17.82 $3,042 - $4,330	243	243 $3,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.